2R01 NS034239/NS/NINDS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2004	1
2008	2
2009	9
2010	9
2011	15
2012	9
2013	11
2014	10
2015	13
2016	4
2021	1
2023	1
2024	0

1

CD4+ effector T cells accelerate Alzheimer's disease in mice.

Machhi J, Yeapuri P, Lu Y, Foster E, Chikhale R, Herskovitz J, Namminga KL, Olson KE, Abdelmoaty MM, Gao J, Quadros RM, Kiyota T, Jingjing L, Kevadiya BD, Wang X, Liu Y, Poluektova LY, Gurumurthy CB, Mosley RL, Gendelman HE. Machhi J, et al. J Neuroinflammation. 2021 Nov 19;18(1):272. doi: 10.1186/s12974-021-02308-7. J Neuroinflammation. 2021. PMID: 34798897 Free PMC article.

2

Amyloid-β specific regulatory T cells attenuate Alzheimer's disease pathobiology in APP/PS1 mice.

Yeapuri P, Machhi J, Lu Y, Abdelmoaty MM, Kadry R, Patel M, Bhattarai S, Lu E, Namminga KL, Olson KE, Foster EG, Mosley RL, Gendelman HE. Yeapuri P, et al. Mol Neurodegener. 2023 Dec 18;18(1):97. doi: 10.1186/s13024-023-00692-7. Mol Neurodegener. 2023. PMID: 38111016 Free PMC article.

3

Bridge between neuroimmunity and traumatic brain injury.

Kelso ML, Gendelman HE. Kelso ML, et al. Curr Pharm Des. 2014;20(26):4284-98. Curr Pharm Des. 2014. PMID: 24025052 Free PMC article. Review.

4

Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.

Gendelman HE, Anantharam V, Bronich T, Ghaisas S, Jin H, Kanthasamy AG, Liu X, McMillan J, Mosley RL, Narasimhan B, Mallapragada SK. Gendelman HE, et al. Nanomedicine. 2015 Apr;11(3):751-67. doi: 10.1016/j.nano.2014.12.014. Epub 2015 Jan 31. Nanomedicine. 2015. PMID: 25645958 Free PMC article. Review.

5

Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease.

Olson KE, Gendelman HE. Olson KE, et al. Curr Opin Pharmacol. 2016 Feb;26:87-95. doi: 10.1016/j.coph.2015.10.006. Epub 2015 Nov 11. Curr Opin Pharmacol. 2016. PMID: 26571205 Free PMC article. Review.

6

Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disorders.

Gendelman HE, Gelbard HA. Gendelman HE, et al. Curr Opin HIV AIDS. 2014 Nov;9(6):585-90. doi: 10.1097/COH.0000000000000111. Curr Opin HIV AIDS. 2014. PMID: 25226025 Free PMC article. Review.

7

Cell-mediated drug delivery.

Batrakova EV, Gendelman HE, Kabanov AV. Batrakova EV, et al. Expert Opin Drug Deliv. 2011 Apr;8(4):415-33. doi: 10.1517/17425247.2011.559457. Epub 2011 Feb 24. Expert Opin Drug Deliv. 2011. PMID: 21348773 Free PMC article. Review.

8

Immunization strategies for Parkinson's disease.

Ha D, Stone DK, Mosley RL, Gendelman HE. Ha D, et al. Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S218-21. doi: 10.1016/S1353-8020(11)70067-0. Parkinsonism Relat Disord. 2012. PMID: 22166440 Review.

9

A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders.

Gendelman HE, Mosley RL. Gendelman HE, et al. J Neuroimmune Pharmacol. 2015 Dec;10(4):645-50. doi: 10.1007/s11481-015-9639-4. Epub 2015 Oct 31. J Neuroimmune Pharmacol. 2015. PMID: 26520433 Free PMC article. Review.

10

Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies.

Edagwa BJ, Zhou T, McMillan JM, Liu XM, Gendelman HE. Edagwa BJ, et al. Curr Med Chem. 2014;21(36):4186-98. doi: 10.2174/0929867321666140826114135. Curr Med Chem. 2014. PMID: 25174930 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

74 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year